Metraipolis › archive › dc_b6704cd22e90

Immunocytokines in cancer immunotherapy: opportunities and challenges — Europe PMC PMID:41568361

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41568361
DOI
10.3389/fonc.2025.1716612
License (as archived)
solo-consultazione
Archived
2026-11-07T00:58:00.352Z
SHA-256 of the archived text
4f49407f1836d33388be52cd050a91d84cf107ae3e7f86946d3a2646a8c583be
Stable URL of this page
https://metraipolis.com/documento/dc_b6704cd22e90

How to cite

Immunocytokines in cancer immunotherapy: opportunities and challenges — Europe PMC PMID:41568361 — Europe PMC (en), https://europepmc.org/article/MED/41568361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6704cd22e90 (Metraipolis archive dc_b6704cd22e90, sha256 4f49407f1836d33388be52cd050a91d84cf107ae3e7f86946d3a2646a8c583be)
BibTeX
@misc{dcb6704cd22e90,
  title = {Immunocytokines in cancer immunotherapy: opportunities and challenges — Europe PMC PMID:41568361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41568361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6704cd22e90; sha256 4f49407f1836d33388be52cd050a91d84cf107ae3e7f86946d3a2646a8c583be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568361. Agents can read the archived copy with the MCP tool read_document.